Safran SA (LON:0IU8)
London · Delayed Price · Currency is GBP · Price in EUR 290.15
+9.55 (3.40%)
At close: Jul 31, 2025
Verve Therapeutics Market Cap
Safran has a market cap or net worth of 101.79 billion as of August 1, 2025. Its market cap has increased by 46.16% in one year.
Market Cap
101.79B
Enterprise Value
100.89B
Revenue
25.18B
Ranking
n/a
PE Ratio
27.48
Stock Price
$290.15
Market Cap Chart
Since August 12, 1999, Safran's market cap has increased from 1.34B to 101.79B, an increase of 7,504.21%. That is a compound annual growth rate of 18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 101.79B | 39.25% |
| Dec 31, 2024 | 73.10B | 26.49% |
| Dec 29, 2023 | 57.79B | 30.55% |
| Dec 30, 2022 | 44.26B | 14.84% |
| Dec 31, 2021 | 38.54B | -13.08% |
| Dec 31, 2020 | 44.35B | -3.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 172.19B |
| HSBC Holdings | 159.21B |
| Shell | 159.14B |
| Unilever | 112.88B |
| British American Tobacco p.l.c. | 90.29B |
| Rolls-Royce Holdings | 89.59B |
| Rio Tinto Group | 76.38B |
| RELX PLC | 71.14B |